Sino Medical Sciences Technology Inc. (SHA: 688108), based in China, has announced that it has received marketing approval from the Center for Medical Device Evaluation for its innovative self-expanding intracranial drug-coated stent system. This approval was granted through the special review channel, recognizing the device’s potential to treat intracranial atherosclerotic stenosis. The stent system is designed to support and open the lumen of the intracranial artery, thereby improving cerebral blood flow and reducing the risk of ischemia, while also effectively preventing restenosis.
This groundbreaking system is the world’s first self-expanding nickel titanium alloy drug-coated stent specifically designed for intracranial atherosclerotic stenosis, developed independently by Sino Medical. It utilizes patented double coating technology, combining eG electronic graft coating with a drug-loaded coating that allows for controlled release. This technology ensures optimal drug release kinetics while achieving effective stent self-expansion and drug coating to mitigate vascular restenosis following microcatheter deployment. The device prioritizes safety, demonstrating no neurotoxicity and significantly lowering the incidence of restenosis and the risk of stroke recurrence, ultimately enhancing the safety and convenience of surgical procedures.- Flcube.com
